David Stenehjem - Dissemin

Papers authored by David Stenehjem

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2016 Diana I. Brixner, David D. Stenehjem

, Cornelia Ulrich

Aspirin and Cancer Risk

Upload

This paper is made freely available by the publisher.

David M. Gill, David D. Stenehjem

, Kinjal Parikh, Joseph Merriman, Arun Sendilnathan, Archana M. Agarwal, Andrew W. Hahn, Sumati Gupta, Srinivas Kiran Tantravahi, Wolfram E. Samlowski, Neeraj Agarwal

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

David D. Stenehjem

, Michael Toole, Joseph Merriman, Kinjal Parikh, Stephanie Daignault, Sarah Scarlett, Peg Esper, Katherine Skinner, Aaron Udager, Srinivas Kiran Tantravahi, David Gill, Alli M. Straubhar, Archana M. Agarwal, Kenneth F. Grossmann, Wolfram E. Samlowski and 3 other authors

Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2

Upload

Sudhir K. Unni, Marisa B. Schauerhamer, Rishi Deka, Jerzy E. Tyczynski, Ancilla W. Fernandes, Vanessa Stevens, Diana I. Brixner, David D. Stenehjem

BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer – an observational cohort study

Download from dx.doi.org

Nazem Akoum, Feras Bader, Maureen Ghanem, David Stenehjem

, Zachary Burningham, Brian C. Sauer

Comparison of the effectiveness and side effects of dofetilide and dronedarone in the treatment of atrial fibrillation during an indicated period in time with perceived equipoise

Download from dx.doi.org

2015 Shiven B. Patel, David D. Stenehjem

, David M. Gill, Srinivas K. Tantravahi, Archana M. Agarwal, JoAnne Hsu, Winston Vuong, Sumanta K. Pal, Neeraj Agarwal

Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies

Upload

David D. Stenehjem

, Brandon K. Bellows

, Kraig M. Yager, Joshua Jones, Rajesh Kaldate, Uwe Siebert, Diana I. Brixner

Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer

Download from onlinelibrary.wiley.com

Bailey,Hanna, Sunil Sharma, Hanna Bailey, Stenehjem,David D., David D. Stenehjem

, Sharma,Sunil

Panobinostat for the treatment of multiple myeloma: the evidence to date

Download from dx.doi.org

Kuan-Ling Kuo, David Stenehjem

, Frederick Albright, Saurabh Ray, Diana Brixner

Treatment Patterns and Outcomes in Patients With Hepatocellular Carcinoma Stratified by Stage-Guided Treatment Categories

Upload

Erin B. Bailey, Srinivas K. Tantravahi, Austin Poole, Archana M. Agarwal, Alli M. Straubhar, Julia A. Batten, Shiven B. Patel, Chesley E. Wells, David D. Stenehjem

, Neeraj Agarwal

Correlation of Degree of Hypothyroidism With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors

Upload

Distributing this paper is prohibited by the publisher

Ursula Rochau, Gaby Sroczynski

, Dominik Wolf, Stefan Schmidt, Beate Jahn

, Martina Kluibenschaedl, Annette Conrads-Frank, David Stenehjem

, Diana Brixner, Jerald Radich, Günther Gastl, Uwe Siebert

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

Upload

This paper is available in a repository.

Srinivas K. Tantravahi, Daniel Albertson, Archana M. Agarwal, Sowmya Ravulapati

, Austin Poole, Shiven B. Patel, Jamil S. Hawatmeh, Alli M. Straubhar, Ting Liu, David D. Stenehjem

, Neeraj Agarwal

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

Download from doi.org

2014 Zachary Reese, Shiven Patel, David D. Stenehjem

, Ignacio Garrido-Laguna

Response to Nab-Paclitaxel plus Gemcitabine in a Patient with Primary Resistance to FOLFIRINOX

Upload

David D. Stenehjem

, Minkyoung Yoo, Sudhir K. Unni, Mukul Singhal, Hillevi Bauer, Kim Saverno, Cheng Quah, Anthony Masaquel, Diana I. Brixner

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

Download from dx.doi.org

David D. Stenehjem

, Frederick Albright, Kuan-Ling Kuo, Karina Raimundo, Hillevi Bauer, Paul J. Shami, Michael W. Deininger, Lei Chen, Diana I. Brixner

Response Monitoring, Tolerability, and Effectiveness of Imatinib Treatment for Chronic Myeloid Leukemia in a Retrospective Research Database

Upload

Jeffrey A. Gilreath, David D. Stenehjem

, George M. Rodgers

Diagnosis and treatment of cancer-related anemia

Upload

2013 Richard E. Nelson, David Stenehjem

, Wallace Akerley

A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis

Upload

Kuan-Ling Kuo, Surasak Saokaew, David D. Stenehjem

The Pharmacoeconomics of Breakthrough Cancer Pain

Download from www.researchgate.net

2012 Kim R. Saverno, Ursula Rochau, David D. Stenehjem

, Kimberly Morley, Uwe Siebert, Diana I. Brixner

Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients

Download from www.jmcp.org

Jeffrey A. Gilreath, David D. Stenehjem

, George M. Rodgers

Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe2+?

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by David Stenehjem